UPDATE: MLV & Co Reiterates On Galena Biopharma On Positive Long-Term Outlook
August 27, 2014 at 07:59 AM EDT
In a report published Wednesday, MLV & Co analyst Vernon T. Bernardino reiterated a Buy rating on Galena Biopharma (NASDAQ: GALE), but ...
